November 20, 2020
Down syndrome symposium highlights clinical, fundamental progress
… developing biomarkers that may indicate the onset of mild cognitive impairment and Alzheimer’s in Down syndrome … a dynamic model for lab studies in which they can now control chromosome 21 dosage in developing brain cells. In …

